| BIONTECH SE SPON. ADRS 1 |
| USA |
| Gesundheit |
| US09075V1026 / A2PSR2 |
| 22UA (Frankfurt) / BNTX (NASDAQ) |
| FRA:22UA, ETR:22UA, 22UA:GR, NASDAQ:BNTX |
| - |
| https://biontech.de/ |
|
BioNTech SE is a German multinational biotechnology company headquartered in Mainz, specializing in the development of immunotherapies and vaccines for cancer and infectious diseases. Founded in 2008 by Uğur Şahin, Özlem Türeci, and Christoph Hub..
>Volltext.. |
| 22633.64 Mio. EUR |
| 8032.18 Mio. EUR |
| 2831.71 Mio. EUR |
| -241.64 Mio. EUR |
| -1078.66 Mio. EUR |
| -4.46 EUR |
| 267.93 Mio. EUR |
| 7690.49 Mio. EUR |
| 440.74 Mio. EUR |
| 6.93 |
| 11.42% |
| -76.28% |
| - |
| - |
| - |
| 02.06.22 - 1.8290012€ |
| BIONTECH |
| 28.04.26 |
|
||||
|
||||
|